Role of minimally invasive surgery versus open approach in patients with early-stage uterine carcinosarcomas: a retrospective multicentric study
- PMID: 32880752
- PMCID: PMC7873090
- DOI: 10.1007/s00432-020-03372-x
Role of minimally invasive surgery versus open approach in patients with early-stage uterine carcinosarcomas: a retrospective multicentric study
Abstract
Objective: The aim of this retrospective study was to compare surgical and survival outcome in only patients with early-stage UCSs managed by laparotomic surgery (LPT) versus minimally invasive surgery (MIS).
Methods: Data were retrospectively collected in four Italian different institutions. Inclusion criteria were UCS diagnosis confirmed by the definitive histological examination, and stage I or II according to the FIGO staging system.
Results: Between August 2000 and March 2019, the data relative to 170 patients bearing UCSs were collected: of these, 95 were defined as early-stage disease (stage I-II) based on the histological report at the primary surgery, and thus were included in this study. Forty-four patients were managed by LPT, and 51 patients were managed by MIS. The operative time was lower in the MIS group versus the LPT group (p value 0.021); the median estimated blood loss was less in the MIS group compared to the median of LPT group (p value < 0.0001). The length of hospital stay days was shorter in the MIS patients (p value < 0.0001). Overall, there were eight (8.4%) post-operative complications; of these, seven were recorded in the LPT group versus one in the MIS group (p value 0.023). There was no difference in the disease-free survival (DFS) and overall survival (OS) between the two groups.
Conclusion: There was no difference of oncologic outcome between the two approaches, in face of a more favourable peri-operative and post-operative profile in the MIS group.
Keywords: Minimally invasive surgery; Open surgery; Uterine carcinosarcoma.
Conflict of interest statement
All the authors report no conflicts of interest. The authors are responsible for the content and writing of the paper.
Figures
Similar articles
-
SUCCOR morbidity: complications in minimally invasive versus open radical hysterectomy in early cervical cancer.Int J Gynecol Cancer. 2024 Feb 5;34(2):203-208. doi: 10.1136/ijgc-2023-004657. Int J Gynecol Cancer. 2024. PMID: 38669163
-
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.Cochrane Database Syst Rev. 2015 Apr 7;(4):CD010260. doi: 10.1002/14651858.CD010260.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2022 Aug 22;8:CD010260. doi: 10.1002/14651858.CD010260.pub3. PMID: 25847525 Updated.
-
Long-term impact of surgical route and tumor size on risk of recurrence among early-stage cervical cancer patients in a managed care population.Int J Gynecol Cancer. 2025 Jul;35(7):101928. doi: 10.1016/j.ijgc.2025.101928. Epub 2025 May 10. Int J Gynecol Cancer. 2025. PMID: 40500640
-
The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study.Int J Gynecol Cancer. 2016 Jan;26(1):141-8. doi: 10.1097/IGC.0000000000000561. Int J Gynecol Cancer. 2016. PMID: 26509850
-
Interventions for the treatment of oral cavity and oropharyngeal cancers: surgical treatment.Cochrane Database Syst Rev. 2023 Aug 31;8(8):CD006205. doi: 10.1002/14651858.CD006205.pub5. Cochrane Database Syst Rev. 2023. PMID: 37650478 Free PMC article.
Cited by
-
Survival after laparoscopy versus laparotomy for apparent early-stage uterine clear cell carcinoma: Results of a large multicenter cohort study.Front Oncol. 2022 Sep 5;12:975485. doi: 10.3389/fonc.2022.975485. eCollection 2022. Front Oncol. 2022. PMID: 36132126 Free PMC article.
-
Sentinel Lymph Node in Aged Endometrial Cancer Patients "The SAGE Study": A Multicenter Experience.Front Oncol. 2021 Oct 19;11:737096. doi: 10.3389/fonc.2021.737096. eCollection 2021. Front Oncol. 2021. PMID: 34737952 Free PMC article.
-
Is the sarcomatous component (homologous vs heterologous) the prognostic "driving force" in early-stage uterine carcinosarcomas? A retrospective multicenter study.J Cancer Res Clin Oncol. 2023 Aug;149(9):6479-6488. doi: 10.1007/s00432-023-04594-5. Epub 2023 Feb 11. J Cancer Res Clin Oncol. 2023. PMID: 36773091 Free PMC article.
-
Sentinel Node Biopsy for Endometrial Cancer by Retroperitoneal Transvaginal Natural Orifice Transluminal Endoscopic Surgery: A Preliminary Study.Front Surg. 2022 May 9;9:907548. doi: 10.3389/fsurg.2022.907548. eCollection 2022. Front Surg. 2022. PMID: 35615644 Free PMC article.
-
The relationship between metabolic syndrome and survival of patients with endometrial cancer: a meta-analysis.Front Oncol. 2024 Oct 21;14:1484109. doi: 10.3389/fonc.2024.1484109. eCollection 2024. Front Oncol. 2024. PMID: 39497714 Free PMC article.
References
-
- Abdulfatah E, Lordello L, Khurram M et al (2019) Predictive histologic factors in carcinosarcomas of the uterus: a multi-institutional study. Int J Gynecol Pathol 38:205–215. 10.1097/PGP.0000000000000497 - PubMed
-
- Akahira J, Tokunaga H, Toyoshima M et al (2006) Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma. Oncology 71:333–340. 10.1159/000107107 - PubMed
-
- Baekelandt MM, Castiglione M (2009) Endometrial carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20:iv29–iv31. 10.1093/annonc/mdp120 - PubMed
-
- Cantrell LA, Blank SV, Duska LR (2015) Uterine carcinosarcoma: a review of the literature. Gynecol Oncol 137:581–588. 10.1016/j.ygyno.2015.03.041 - PubMed
-
- Carlson J, McCluggage WG (2019) Reclassifying endometrial carcinomas with a combined morphological and molecular approach. Curr Opin Oncol 31:411–419. 10.1097/CCO.0000000000000560 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical